Experimental Ebola Drug Shows Promise

ZMapp effectively rescued macaques from Ebola in a small trial, but it could be several months before supplies of the drug meet the growing human demand for it.

By | September 2, 2014

WIKIMEDIA, PLOS BIOLOGYAn experimental Ebola serum that was given to some patients during the ongoing Ebola outbreak in West Africa “exceeds the efficacy of any other therapeutics described so far,” an international team led by investigators at the Public Health Agency of Canada reported in Nature last week (August 29). In a study on 19 Ebola-infected macaques, Mapp Biopharmaceutical’s monoclonal antibody cocktail ZMapp rescued all of the animals when treatment was initiated within five days post-infection, when they’d already reached an advanced disease stage.

“To actually be able to reverse all those symptoms and signs and bring them back to baseline, I think that is pretty astounding,” Kartik Chandran of the Albert Einstein College of Medicine who was not involved in the study told The New York Times. “If you are going to give somebody something during this outbreak, this would be it.”

Unfortunately, while the therapeutic has shown promise in people who have received it, supplies of the drug have since run out. Last month, Mapp Biopharmaceutical said its supply of ZMapp had been exhausted. While the company is working to make more, the manufacturing process takes months. In a statement to the New York Times, Biomedical Advanced Research and Development Authority Director Robin Robinson said that his agency expects there will be enough ZMapp to conduct a Phase 1 clinical trial is expected by the end of the year.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Sue50

Sue50

Posts: 11

September 5, 2014

I'm so glad possibly a vaccine for the fast mutating plague. So are their any plans if this gets loose in the USA, say a small outbreak 1000 people. I here their is only 4 medical centers in the whole country equiped to handle this. Will it be a mass panic? Who would call the shots?

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham